The global digital biomarker market is estimated to be valued at USD 4,850 Mn in 2026 and is expected to reach USD 16,900 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 19.5% from 2026 to 2033. Digital biomarkers are considered to be a revolutionary development in modern healthcare since they provide an opportunity for quantitative analysis of biological data by means of various digital technologies like wearable devices, smartphones, and other types of sensors. As opposed to regular biomarkers, which require frequent visits to clinics and tests, digital biomarkers allow collecting information continuously and passively, thus allowing for a more accurate assessment of patients' health, progress of various diseases, and treatment outcomes. The evolution of digital biomarkers is contributing to the transformation of current healthcare towards data-driven and outcomes-oriented models.
The global digital biomarker industry includes various applications in therapeutic areas that include cardiovascular diseases, neurological disorders, respiratory disorders, mental health conditions, and others. Digital biomarkers can be generated from a variety of data sources, including physiological information, behavioral data, environmental indicators, and other types of information. Technological advancements in sensors, cloud computing, and data aggregation are contributing to the growth and adoption of digital biomarkers.
Market Dynamics
The global digital biomarker market has been driven by increased digitization of healthcare operations and value-driven healthcare delivery and research. More specifically, stakeholders in the healthcare field are looking for a way to gather frequent and objective data on patients to improve their decision-making capabilities and patient treatment outcomes. With the help of digital biomarkers, patients can collect data and use it as quantifiable digital endpoints that will be applied in clinical settings and pharmaceutical research. Additionally, cloud computing systems, as well as mHealth technology and improved data interoperability, increase the scalability and applicability of the aforementioned solutions.
However, the limitations of using digital biomarkers in healthcare include the inability to control the variability of data generated across different devices, insufficiently validated solutions, and difficulties connected to data governance. Nonetheless, multiple opportunities lie in the application of digital twin technology, multi-modal data analysis, and collaboration among different parties from various sectors including healthcare, pharmaceuticals, and technology. The expansion of the application range of digital biomarkers from research to population health management, risk identification, and treatment can further contribute to the growth of the market for digital biomarker.
Key Features of the Study
• This report provides in-depth analysis of the global digital biomarker market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global digital biomarker market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include AliveCor Inc., BioSensics, Evidation Health, Empatica Inc., Koneksa Health, Huma Therapeutics, Altoida AG, IXICO plc, Oura Health, and Verily Life Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global digital biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital biomarker market
Market Segmentation
• Type Insights (Revenue, USD Mn, 2021 - 2033)
o Diagnostic Biomarkers
o Monitoring Biomarkers
o Predictive and Prognostic Biomarkers
• Data Type Insights (Revenue, USD Mn, 2021 - 2033)
o Physiological Data
o Behavioral Data
o Biochemical / Multi-modal Data
• Technology Platform Insights (Revenue, USD Mn, 2021 - 2033)
o Wearable Devices
o Mobile Applications
o Sensors and Remote Monitoring Devices
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Pharmaceutical and Biotechnology Companies
o Healthcare Providers
o Research Organizations
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
 U.S.
 Canada
o Latin America
 Brazil
 Argentina
 Mexico
 Rest of Latin America
o Europe
 Germany
 U.K.
 Spain
 France
 Italy
 Russia
 Rest of Europe
o Asia Pacific
 China
 India
 Japan
 Australia
 South Korea
 ASEAN
 Rest of Asia Pacific
o Middle East
 GCC Countries
 Israel
 Rest of Middle East
o Africa
 South Africa
 North Africa
 Central Africa
• Key Players Insights
o AliveCor Inc.
o BioSensics
o Evidation Health
o Empatica Inc.
o Koneksa Health
o Huma Therapeutics
o Altoida AG
o IXICO plc
o Oura Health
o Verily Life Sciences

Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
 Market Definition and Scope
o Executive Summary
 Global Digital Biomarker Market, By Type
 Global Digital Biomarker Market, By Data Type
 Global Digital Biomarker Market, By Technology Platform
 Global Digital Biomarker Market, By End User
 Global Digital Biomarker Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Digital Biomarker Market, By Type, 2021-2033, (USD Mn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 - 2033
 Segment Trends
o Diagnostic Biomarkers
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Monitoring Biomarkers
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Predictive and Prognostic Biomarkers
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Digital Biomarker Market, By Data Type, 2021-2033, (USD Mn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 - 2033
 Segment Trends
o Physiological Data
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Behavioral Data
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Biochemical / Multi-modal Data
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Digital Biomarker Market, By Technology Platform, 2021-2033, (USD Mn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 - 2033
 Segment Trends
o Wearable Devices
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Mobile Applications
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Sensors and Remote Monitoring Devices
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Digital Biomarker Market, By End User, 2021-2033, (USD Mn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022 - 2033
 Segment Trends
o Pharmaceutical and Biotechnology Companies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Healthcare Providers
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Research Organizations
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Digital Biomarker Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
 Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
 Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
 Regional Trends
o North America
 Introduction
 Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
 Introduction
 Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
 Introduction
 Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
 Introduction
 Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
 Introduction
 Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
 Introduction
 Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
 Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
9. Competitive Landscape
o AliveCor Inc.
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o BioSensics
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Evidation Health
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Empatica Inc.
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Koneksa Health
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Huma Therapeutics
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Altoida AG
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o IXICO plc
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Oura Health
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
o Verily Life Sciences
 Company Highlights
 Product Portfolio
 Key Developments
 Financial Performance
 Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on 'Digital Biomarker Market' - Global forecast to 2033